EGFR and non-small cell lung carcinoma: The combination of molecular targeted therapy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and photodynamic therapy PDT can combat non-small cell lung cancer (NSCLC) with effective synergistic results (Qiao et al., 2021).